Results 211 to 220 of about 375,217 (345)
ABSTRACT Understanding how pancreas size and shape change with normal aging is critical for establishing a baseline to detect deviations in type 2 diabetes and other pancreatic disease. We measure pancreas size and shape using morphological measurements from early development through aging (ages 0–90).
Lucas W. Remedios +13 more
wiley +1 more source
Quantitative CT Assessment of Skeletal Muscle and Abdominal Fat Distribution: Predictive Value for Type 2 Diabetes Mellitus. [PDF]
Zhang B +8 more
europepmc +1 more source
Polycystic ovary syndrome and abdominal fat: is there a relationship? [PDF]
Macruz CF, Lima SMRR.
europepmc +1 more source
Grooved Surface of the Obturator Internus Muscle With Two Distinct Adjacent Parts
ABSTRACT The specific anatomical features of the obturator internus, particularly those of its medial surface, remain insufficiently characterized. This study investigated the morphology of the obturator internus muscle by focusing on the shape of its medial surface and potential age‐related changes.
Satoru Muro +4 more
wiley +1 more source
Succinic acid-driven gut-fat axis orchestrates abdominal fat deposition in chickens via adipocyte-macrophage crosstalk. [PDF]
Chen J +8 more
europepmc +1 more source
PRISMA study flow diagram. ABSTRACT Introduction Advances in HIV management have transformed HIV into a chronic condition, resulting in improved prognosis and increased survival among people living with HIV (PLWH). Traditional risk factors for metabolic dysfunction‐associated steatotic liver disease (MASLD)—including dyslipidemia—are prevalent in PLWH.
Yovita Hartantri +6 more
wiley +1 more source
Gut microbiota composition and dietary interventions modulate abdominal fat deposition in poultry: Mechanisms and applications. [PDF]
Gibril BAA, Tu X, Chai X, Xu J.
europepmc +1 more source
Abdominal dermal fat grafting in Parry-Romberg syndrome
Ahmed A. Al-Kinani, Marwan Ghanim Al-Tae
openalex +2 more sources
Fezolinetant is a first‐in‐class, selective, non‐hormonal, neurokinin 3 receptor antagonist that is approved for the treatment of moderate to severe vasomotor symptoms due to menopause. In a phase 2b clinical study (n = 352), nine study participants experienced elevations in serum transaminases exceeding three times the upper limit of normal.
Jace C. Nielsen +11 more
wiley +1 more source
Prognostic significance of preoperative abdominal fat thickness for pancreatic ductal adenocarcinoma. [PDF]
Zhang S, Xu L, Gao D, Zhang H, Wei S.
europepmc +1 more source

